Nexalin Technology Inc. (NXL) stock news · rev $301.6K
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
This NXL news page leads with what Nexalin Technology Inc. filed — not a scraped headline mill.
No cached 8-K sentence for NXL yet. We will not pad this page with generic market recap.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NXL stock page; for the tape open the quote page.
NXL stock news FAQ
What are NXL's latest revenue and net income?
Latest cached Nexalin Technology Inc. (NXL) revenue for Dec 31, 2025 was $301.6K. Net income was -$8.2M. Statements: https://lician.com/financials/nxl
How did NXL revenue change from the prior cached period?
Cached Nexalin Technology Inc. (NXL) revenue was up 78.8% from $168.7K (Dec 31, 2024) to $301.6K (Dec 31, 2025). Statements: https://lician.com/financials/nxl
What is NXL's market cap?
Nexalin Technology Inc. (NXL) market cap is $8.5M on the latest cached fundamentals snapshot.
What kind of company is NXL?
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Where is NXL stock news listed?
Cached stock news for Nexalin Technology Inc. (NXL) is listed at https://lician.com/news/nxl. Filings: https://lician.com/sec/nxl
Not investment advice.